Collecting samples from lung cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to create a comprehensive specimen banking program for patients diagnosed with lung cancer. By collecting biological samples, the researchers hope to advance the understanding of lung cancer biology, identify early detection markers, and develop better therapeutic strategies. The program will also explore potential screening and prevention methods, ultimately contributing to improved patient outcomes. The study is observational and focuses on gathering data without specific interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
2. Oral and written informed consent

Exclusion Criteria:

1\. Any individual who does not give oral and written consent for participation

Where it's running

• University of Colorado Cancer Center
  Aurora, Colorado, United States Recruiting

Study contacts

• Principal investigator: Adriaan VanBokhoven, PhD — University of Colorado, Denver
• Study coordinator: Brandi Kubala
• Email: brandi.kubala@cuanschutz.edu
• Phone: 303-724-1657

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-assisted longitudinal CT to guide indeterminate lung nodules

  This trial tests whether giving doctors an AI report that tracks nodules over serial CT scans helps reduce unnecessary benign lung resections in patients with indeterminate nodules.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07895277

• MRD-guided postoperative monitoring and adaptive treatment for resectable NSCLC

  This study tests a personalized follow-up and treatment plan using ctDNA MRD testing and pathology to guide adjuvant therapy after surgery for stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07894458

• Telerehabilitation exercise program after lung cancer surgery

  A remote rehabilitation program with guided exercises is tested to help adults after lung cancer surgery recover better.

  Recruiting University of Seville · Seville, Andalusia · NCT07861282

• Impact of Exercise on Tumor Immunity in NSCLC Patients Receiving Neoadjuvant Chemo-Immunotherapy

  A structured exercise program is being tested to see if it boosts immune cells in the tumor for patients with resectable NSCLC undergoing pre-surgery chemo-immunotherapy.

  Recruiting at 2 sites Centre Leon Berard · Lyon, Rhône and 1 other locations · NCT07786909

• Low-Dose CT Lung Cancer Screening in Kuwait: Feasibility and Uptake

  This pilot tests whether offering low-dose CT lung cancer screening to high-risk adults in Kuwait is workable and acceptable, with about 500 participants completing a baseline scan.

  Recruiting Chest Diseases Hospital, Ministry of Health, Kuwait · Kuwait City · NCT07766538

• Nitride-based Raman biochip for lung cancer diagnosis and monitoring

  A large observational study in Taiwan will test whether a blood-based nitride-based Raman biochip can help diagnose lung cancer and monitor patients over time.

  Recruiting Taichung Veterans General Hospital · Taichung · NCT07755020

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.